$RPTX Repare Therapeutics Inc. Insider Trading Week 50/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Repare Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Repare Therapeutics Inc. in week 50/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | M | 2.06 | 8,321 | 17,158 | 85,707 | |
| Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | M | 1.64 | 2,080 | 3,405 | 29,538 | |
| Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | M | 1.64 | 6,876 | 11,256 | 4,122 | |
| Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 35.10 | 200 | 7,020 | 85,229 | 85.4 K to 85.2 K (-0.23 %) |
| Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 34.59 | 8,121 | 280,905 | 85,429 | 93.6 K to 85.4 K (-8.68 %) |
| Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Buy | M | 2.06 | 8,321 | 17,158 | 93,550 | 85.2 K to 93.6 K (+9.76 %) |
| Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 36.01 | 934 | 33,633 | 85,229 | 86.2 K to 85.2 K (-1.08 %) |
| Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 35.17 | 8,022 | 282,134 | 86,163 | 94.2 K to 86.2 K (-8.52 %) |
| Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Buy | M | 1.64 | 2,080 | 3,405 | 94,185 | 92.1 K to 94.2 K (+2.26 %) |
| Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Buy | M | 1.64 | 6,876 | 11,256 | 92,105 | 85.2 K to 92.1 K (+8.07 %) |
| Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 21,707 | 0 | 192,683 | 214.4 K to 192.7 K (-10.13 %) |
| Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 9,497 | 0 | 84,301 | 93.8 K to 84.3 K (-10.12 %) |
| Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 8,579 | 0 | 76,158 | 84.7 K to 76.2 K (-10.12 %) |
| Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 285,217 | 0 | 2,531,804 | 2.8 M to 2.5 M (-10.12 %) |
| Dec 17 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 21,707 | 0 | 192,683 | 214.4 K to 192.7 K (-10.13 %) |
| Dec 17 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 9,497 | 0 | 84,301 | 93.8 K to 84.3 K (-10.12 %) |
| Dec 17 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 8,579 | 0 | 76,158 | 84.7 K to 76.2 K (-10.12 %) |
| Dec 17 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 285,217 | 0 | 2,531,804 | 2.8 M to 2.5 M (-10.12 %) |
| Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 21,707 | 0 | 192,683 | 214.4 K to 192.7 K (-10.13 %) |
| Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 9,497 | 0 | 84,301 | 93.8 K to 84.3 K (-10.12 %) |
| Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 8,579 | 0 | 76,158 | 84.7 K to 76.2 K (-10.12 %) |
| Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 285,217 | 0 | 2,531,804 | 2.8 M to 2.5 M (-10.12 %) |